Dr. Shaun Setty Is Appointed CMO of HD Medical

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Dr. Shaun Setty is a cardiothoracic surgeon in Los Angeles, CA, with over 13 years of experience in pediatric and adult congenital cardiac surgery.

Dr. Shaun Setty is triple-board certified in surgery, thoracic surgery, and congenital heart surgery, with experience in all aspects of cardiac surgery.

Dr. Setty began his medical education at the Medical College of Ohio, where he graduated with Alpha Omega Alpha honors, followed by a general surgery residency at Oregon Health & Science University. He went on to complete his cardiothoracic surgery training at the University of Minnesota/Lillehei Heart Institute, the birthplace of modern cardiac surgery.

Dr. Setty continued on to do his congenital cardiac surgery fellowship at the renowned Royal Children’s Hospital in Melbourne, Australia, and spent a year at Green Lane Hospital in New Zealand as a pediatric and adult cardiac surgery fellow. He also has experience in robotic and transplant surgery and is currently involved in multiple basic and clinical cardiac research projects.

Setty was integral in the launch of HD Medical’s flagship product, HD Steth. HD Steth is the first of its kind FDA Cleared Intelligent Stethoscope with ECG and PCG in a single device. This simple-to-use tool has a familiar stethoscope form factor and workflow that enables clinicians, hospitals, and telehealth providers to capture, record, replay, and visualize heart sounds and ECG waveforms instantaneously on the HD Steth Android or Apple iOS app.

The HD Steth app delivers superior ECG waveforms with the ability to detect high-frequency heart sounds indicative of murmurs. Medical professionals now have access to patented algorithms and high-definition visualization, in addition to noise-cancellation technologies that support an instantaneous diagnosis by a remote specialist.

“I’m excited to join HD Medical at this critical time in their growth,” says Dr. Shaun Setty. “With HD Steth rising in popularity plus the introduction of our new HealthyU all-in-one remote patient monitor at CES in January, I believe HD Medical is well-positioned to be a leader in the stethoscope and remote monitoring space.”

The input and overall direction from Dr. Setty will aid in the continued development and growth of HD Medical as a whole,” says Arvind Thiagarajan, founder and CEO of HD Medical. “Dr. Setty has proven to be an invaluable advisor, and we are thrilled to welcome him as our new CMO. Additionally, his clinical vision will continue to drive our mission to save lives through early detection of CVD.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.